Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation.

Yazun JarrarSara AbudahabGhasaq Abdul-WahabDana ZaiterAbdalla MadaniSara J AbaalkhailDina AbulebdahHussam AlhawariRami Musleh Su-Jun Lee

Published in: Pharmacogenomics and personalized medicine (2023)

gene is a potential biomarker for the development of T2DM and changes in triglyceride levels among Jordanians. However, it is important to note that our sample size was limited; therefore, further clinical studies with a larger cohort are necessary to validate these findings.

Keyphrases

genome wide
copy number
glycemic control
dna methylation
genome wide identification
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
weight loss
insulin resistance